Skip to main content

Home/ Groups/ OARS funding Cancer
MiamiOH OARS

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is to reduce cancer health disparities in health outcomes thereby reducing the excess disease burden of tobacco use within these groups. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.
MiamiOH OARS

PAR-18-654: Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as

    (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies,

    (2) the development and testing of new methodologies and models, and

    (3) secondary data analyses



    This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.
MiamiOH OARS

Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinica... - 0 views

  •  
    This FOA seeks applications for clinical trials testing interventions targeting diabetes distress in individuals with T1D and/or their caregivers, with the goal of understanding whether lowering diabetes distress will improve glycemic control and quality of life.
MiamiOH OARS

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical T - 0 views

  •  
    ype 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomaterials engineering, are especially encouraged.
MiamiOH OARS

Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans. For applicants submitting U54 renewal applications, research under this FOA should culminate in an optimized lead compound ready for advanced development. The Centers will contain at least three research projects supported by an administrative core, up to three optional scientific cores, and a research education core. Each research project must include milestones that create discrete go or no-go decision points in a progressive translational study plan.
MiamiOH OARS

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.
MiamiOH OARS

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.
MiamiOH OARS

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical T... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
MiamiOH OARS

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R0... - 0 views

  •  

    This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools (e.g., mTurk), online search data, Ecological Momentary Assessment, neuroscience and biobehavioral approaches to communication, and geographic information systems. Studies should assess outcomes related to cancer prevention and control (e.g., knowledge, attitudes, beliefs, perceived risk, decision making in screening and treatment, information inequalities, social support, shared decision making, persuasion, caregiving, behavioral intentions, preventive behaviors, and policy support, among others). Also listed under R21
MiamiOH OARS

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
MiamiOH OARS

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R0... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools (e.g., mTurk), online search data, Ecological Momentary Assessment, neuroscience and biobehavioral approaches to communication, and geographic information systems. Studies should assess outcomes related to cancer prevention and control (e.g., knowledge, attitudes, beliefs, perceived risk, decision making in screening and treatment, information inequalities, social support, shared decision making, persuasion, caregiving, behavioral intentions, preventive behaviors, and policy support, among others). This FOA utilizes the Exploratory/Developmental Grant (R21) mechanism, which supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research.
MiamiOH OARS

Einstein Forum - Albert Einstein-Stipendium - 0 views

  •  
    The Albert Einstein Fellowship supports creative, interdisciplinary thought by giving young scholars the chance to pursue research outside their previous area of work.

    Candidates must be under 35 and hold a university degree in the humanities, in the social sciences, or in the natural sciences. Applications for 2019 should include a CV, a two-page project proposal, and two letters of recommendation. All documents must be received by April 15, 2018.

    At the end of the fellowship period, the fellow will be expected to present his or her project in a public lecture at the Einstein Forum and at the Daimler and Benz Foundation. The Einstein Fellowship is not intended for applicants who wish to complete an academic study they have already begun.

    A successful application must demonstrate the quality, originality, and feasibility of the proposed project, as well as the superior intellectual development of the applicant. It is not relevant whether the applicant has begun working toward, or currently holds, a PhD. The proposed project need not be entirely completed during the time of the fellowship, but can be the beginning of a longer project.

    PLEASE NOTE THAT NO FELLOWSHIPS WILL BE GIVEN FOR DISSERTATION RESEARCH. THE PROPOSED PROJECT MUST BE SIGNIFICANTLY DIFFERENT IN CONTENT, AND PREFERABLY FIELD AND FORM, FROM THE APPLICANT'S PREVIOUS WORK.
MiamiOH OARS

PA-18-629: Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R... - 0 views

  •  
    Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
MiamiOH OARS

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 - 0 views

  •  
    Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
MiamiOH OARS

Cooperative Threat Reduction Metrics - 0 views

  •  
    ISN/CTR seeks to build self-sufficient nuclear, biological, and chemical security with partner governments. Since 2012, ISN/CTR has funded the development of an evaluation tool to annually measure the effectiveness of its ISN/CTR programming. The ISN/CTR metrics tool is designed to assess the human element of threat reduction as evidenced by the establishment of nuclear, biological, and chemical security cultures in partner countries, institutions, and individuals. For the current NOFO, ISN/CTR is seeking a new analysis of program work beyond 2017 using this evaluation tool for programming that occurred in ISN/CTR partner countries.
MiamiOH OARS

Survey about OARS professional development offerings - 0 views

  •  
    Miami University researchers can provide input about the professional development opportunities they'd like to see OARS offer in the next year by completing this 5-minute survey.
MiamiOH OARS

2018 LUNGevity Career Development Awards | LUNGevity Foundation - 0 views

  •  
    LUNGevity's Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas.
    Applicants must be within the first five years of their faculty appointment.
    The Career Development Awards are mentored awards; a mentoring plan is part of the required submission.
    Projects that will be funded in 2018 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.
    Career Development Awards may be for a maximum of $300,000:
    $100,000 per year for 3 years
MiamiOH OARS

PFD Research Foundation - 0 views

  •  
    The PFD Research Foundation together with the June Allyson Foundation has awarded over $1.5 million in grants to AUGS members since 1998. The Foundation serves the medical profession by supporting promising, innovative research regarding the causes, prevention, cure and treatment of pelvic floor disorders.
    Foundation research funds are made available to qualified AUGS members to pursue their research question. Goals of this research grant program are to support the completion of research projects which will lead to publication and presentation at future AUGS Annual Scientific Meetings and to support the development of researchers in the field who will go on to obtain additional funding for future research on pelvic floor disorders.
    Applicants can submit proposals for the following research awards:
    PFD Research Foundation Fellow Research Award: A two-year grant awarded to a fellow for clinical/patient-oriented, educational, or lab-based/basic science research.
    PFD Research Foundation Faculty Research Award: A two-year grant awarded to a junior faculty or affiliate member for clinical/patient-oriented, educational, or lab-based/basic science research.
    June Allyson Memorial Fund Research Award: A two-year grant awarded to a fellow for lab-based/basic science research.
    PFD Research Foundation and ICA IC/PBS Research Grant: A one-year grant awarded to a fellow, junior faculty or affiliate member of AUGS and ICA for research related to interstitial cystitis.
MiamiOH OARS

2018 Bladder Cancer Research Innovation Award - 0 views

  •  
    The aim of the 2018 Bladder Cancer Research Innovation Award is to support exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding or the management of bladder cancer. The proposed research may be basic, translational, or clinical but must have direct applicability and relevance to bladder cancer and address one of the questions of interest (see below). Proposals for innovative projects that will develop preliminary data necessary to prepare and submit a competitive research grant application to a major funding agency are encouraged. The award is available to full time, independent investigators who are affiliated with a non-profit academic, medical or research institution within the United States or Canada. Candidates not currently performing bladder cancer research are encouraged to apply. Proposals that involve a multidisciplinary approach and/or multi-institutional collaboration are encouraged.



    The award is for $300,000 over two years ($150,000 per year) for direct research expenses, which may include salary and benefits for postdoctoral or clinical research fellows, and/or research assistants; research/lab supplies; and equipment. The second year of funding is dependent on approval after a one year progress report has been submitted and reviewed by BCAN.
MiamiOH OARS

National Partnerships to Promote Cancer Surveillance Standards and Support Data Quality - 0 views

  •  
    Centers for Disease Control and Prevention (CDC) supports a variety of activities in health departments and organizations aimed at preventing and controlling cancer, the second leading cause of death in US men and women. Since the passage of the Cancer Registries Amendment Act in 1992, the National Program of Cancer Registries (NPCR) has collected data on cancer occurrence, extent, treatment and outcomes in over 45 states and jurisdictions, representing 96% of the US population. CDC's Division of Cancer Prevention and Control (DCPC) has supported successful partnerships with national organizations to define standardized practices in U.S. cancer surveillance and assure and complete, timely, and high-quality data for the official federal U.S. Cancer Statistics. The purpose of this funding opportunity is to build strong partnerships among national organizations involved directly in cancer surveillance in order to enhance the data quality and operational efficiency of CDC’s National Program of Cancer Registries (NPCR). This program has three essential components: 1) Education, Translation and Quality Control of cancer surveillance standards and best practices; 2) Cancer Staging Collaboration and Support; and 3) Standardization and Support for Laboratory and Biomarker Electronic Reporting. The overarching goal of this project is to collaboratively define and promote uniform standards in cancer staging, collection and reporting. Funded entities will identify specific enhancement needs of cancer registries and support cancer surveillance professionals, including reporters (e.g. facilities, labs), tumor registrars, and registries to submit high quality, standardized data via central cancer registries to NPCR. Relevant performance measures will be used to assess the recipients’ activities that enhance the standards, quality, and operations of NPCR cancer surveillance system.
1 - 20 of 489 Next › Last »
Showing 20 items per page